Lipid-Polymer Hybrid Nanoparticles for Controlled Delivery of Hydrophilic and Lipophilic Doxorubicin for Breast Cancer Therapy [Erratum]
Tahir N, Madni A, Correia A, et al. Int J Nanomed. 2019;14:4961– 4974. On page 4967, Figure 3 artwork is incorrect, Figure 4 artwork was mistakenly added by the Editorial staff during the publication process.Read the original article
Saved in:
Main Authors: | Tahir N, Madni A, Correia A, Rehman M, Balasubramanian V, Khan MM, Santos HA |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/88a4e47174c54953b8a9e3413f29cb35 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy
by: Tahir N, et al.
Published: (2019) -
MRI-guided targeting delivery of doxorubicin with reduction-responsive lipid-polymer hybrid nanoparticles
by: Wu B, et al.
Published: (2017) -
Review on Lipophilic and Hydrophilic Extractives in Tissues of Common Beech
by: Viljem Vek, et al.
Published: (2016) -
Co-Delivery of Curcumin and Cisplatin to Enhance Cytotoxicity of Cisplatin Using Lipid-Chitosan Hybrid Nanoparticles
by: Khan MM, et al.
Published: (2020) -
Hydrophilic mesoporous carbon nanospheres with high drug-loading efficiency for doxorubicin delivery and cancer therapy
by: Wang H, et al.
Published: (2016)